Here are five notes about the company’s financial performance for the fourth quarter of 2019 and the full fiscal year, which ended Dec. 31, 2019:
1. Teladoc posted a 27 percent increase in year-over-year fourth quarter revenue at $156.5 million.
2. The telehealth company’s total virtual visits increased 57 percent in 2019 to 4.1 million.
3. Subscription access fees contributed to most of Teladoc’s revenue at $356.7 million for the year, up 29 percent from $277.1 million in 2018.
4. Teladoc posted a $98.9 million net loss for the full year, compared to $97.1 million for the full year 2018.
5. Teladoc anticipates its full-year 2020 revenue to be in the range of $695 million to $710 million and total visits to be between 5.5 million and 5.9 million.
More articles on telehealth:
Viewpoint: Telemedicine needs 5G before it can transform healthcare
Viewpoint: Why telehealth is ‘the Netflix of medicine’
Teladoc Health welcomes Froedtert Health CEO to board of directors
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
